• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

验证纵向数据亚组识别的有效性。

Validating effectiveness of subgroup identification for longitudinal data.

作者信息

Andrews Nichole, Cho Hyunkeun

机构信息

Department of Statistics, Western Michigan University, Kalamazoo, MI 49008, USA.

Department of Biostatistics, University of Iowa, Iowa City, IA 52242, USA.

出版信息

Stat Med. 2018 Jan 15;37(1):98-106. doi: 10.1002/sim.7500. Epub 2017 Sep 25.

DOI:10.1002/sim.7500
PMID:28948635
Abstract

In clinical trials and biomedical studies, treatments are compared to determine which one is effective against illness; however, individuals can react to the same treatment very differently. We propose a complete process for longitudinal data that identifies subgroups of the population that would benefit from a specific treatment. A random effects linear model is used to evaluate individual treatment effects longitudinally where the random effects identify a positive or negative reaction to the treatment over time. With the individual treatment effects and characteristics of the patients, various classification algorithms are applied to build prediction models for subgrouping. While many subgrouping approaches have been developed recently, most of them do not check its validity. In this paper, we further propose a simple validation approach which not only determines if the subgroups used are appropriate and beneficial but also compares methods to predict individual treatment effects. This entire procedure is readily implemented by existing packages in statistical software. The effectiveness of the proposed method is confirmed with simulation studies and analysis of data from the Women Entering Care study on depression.

摘要

在临床试验和生物医学研究中,会对各种治疗方法进行比较,以确定哪种方法对疾病有效;然而,个体对相同治疗的反应可能会有很大差异。我们针对纵向数据提出了一个完整的流程,该流程能够识别出可能从特定治疗中受益的人群亚组。我们使用随机效应线性模型对个体治疗效果进行纵向评估,其中随机效应可确定随着时间推移对治疗的正向或负向反应。结合个体治疗效果和患者特征,应用各种分类算法来构建用于亚组划分的预测模型。虽然最近已经开发出了许多亚组划分方法,但其中大多数都没有检验其有效性。在本文中,我们进一步提出了一种简单的验证方法,该方法不仅能确定所使用的亚组是否合适且有益,还能比较预测个体治疗效果的方法。整个过程可以通过统计软件中的现有程序轻松实现。通过模拟研究以及对女性抑郁症护理研究数据的分析,证实了所提方法的有效性。

相似文献

1
Validating effectiveness of subgroup identification for longitudinal data.验证纵向数据亚组识别的有效性。
Stat Med. 2018 Jan 15;37(1):98-106. doi: 10.1002/sim.7500. Epub 2017 Sep 25.
2
Subgroup analysis with semiparametric models toward precision medicine.亚组分析与精准医学的半参数模型。
Stat Med. 2018 May 20;37(11):1830-1845. doi: 10.1002/sim.7638. Epub 2018 Mar 25.
3
Detecting treatment-subgroup interactions in clustered data with generalized linear mixed-effects model trees.基于广义线性混合效应模型树检测聚类数据中的治疗亚组交互作用。
Behav Res Methods. 2018 Oct;50(5):2016-2034. doi: 10.3758/s13428-017-0971-x.
4
PSICA: Decision trees for probabilistic subgroup identification with categorical treatments.PSICA:用于概率亚组识别的分类治疗决策树。
Stat Med. 2019 Sep 30;38(22):4436-4452. doi: 10.1002/sim.8308. Epub 2019 Jun 27.
5
Flexible alpha allocation strategies for confirmatory adaptive enrichment clinical trials with a prespecified subgroup.具有预设亚组的确认性适应性富集临床试验的灵活 alpha 分配策略。
Stat Med. 2018 Oct 30;37(24):3387-3402. doi: 10.1002/sim.7851. Epub 2018 Jun 26.
6
Classification of longitudinal data through a semiparametric mixed-effects model based on lasso-type estimators.基于套索型估计量的半参数混合效应模型对纵向数据进行分类。
Biometrics. 2015 Jun;71(2):333-43. doi: 10.1111/biom.12280. Epub 2015 Jan 30.
7
A comparison of subgroup identification methods in clinical drug development: Simulation study and regulatory considerations.临床药物开发中亚组识别方法的比较:模拟研究与监管考量
Pharm Stat. 2019 Oct;18(5):600-626. doi: 10.1002/pst.1951. Epub 2019 Jul 3.
8
Subgroup identification for treatment selection in biomarker adaptive design.生物标志物适应性设计中用于治疗选择的亚组识别
BMC Med Res Methodol. 2015 Dec 9;15:105. doi: 10.1186/s12874-015-0098-7.
9
Studying treatment-effect heterogeneity in precision medicine through induced subgroups.通过诱导亚组研究精准医学中的治疗效果异质性。
J Biopharm Stat. 2019;29(3):491-507. doi: 10.1080/10543406.2019.1579220. Epub 2019 Feb 22.
10
A mechanistic nonlinear model for censored and mismeasured covariates in longitudinal models, with application in AIDS studies.纵向模型中删失和测量误差协变量的一种机制性非线性模型及其在艾滋病研究中的应用。
Stat Med. 2018 Jan 15;37(1):167-178. doi: 10.1002/sim.7515. Epub 2017 Oct 16.

引用本文的文献

1
Quality of observational studies of clinical interventions: a meta-epidemiological review.临床干预措施的观察性研究质量:一项Meta 流行病学评价。
BMC Med Res Methodol. 2022 Dec 7;22(1):313. doi: 10.1186/s12874-022-01797-1.
2
Using population crossover trials to improve the decision process regarding treatment individualization in N-of-1 trials.利用群体交叉试验改进 N-of-1 试验中关于个体化治疗决策的过程。
Stat Med. 2021 Sep 10;40(20):4345-4361. doi: 10.1002/sim.9030. Epub 2021 Jul 2.
3
Measuring individual benefits of psychiatric treatment using longitudinal binary outcomes: Application to antipsychotic benefits in non-cannabis and cannabis users.
使用纵向二分类结局衡量精神科治疗的个体获益:非大麻和大麻使用者抗精神病药物获益的应用。
J Biopharm Stat. 2020 Sep 2;30(5):916-940. doi: 10.1080/10543406.2020.1765371. Epub 2020 Jun 8.